Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast AsiaGlobeNewsWire • 05/21/26
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—OGN, MMTX, VRE, and ESQGlobeNewsWire • 05/05/26
Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 04/30/26
Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash DealThe Motley Fool • 04/27/26
Organon Shares Rally 16% in Premarket as Sun Pharma Announces BuyoutZacks Investment Research • 04/27/26
Johnson Fistel Investigates Potential Breaches of Fiduciary Duty in Connection with the Proposed Acquisition of Organon by Sun PharmaceuticalGlobeNewsWire • 04/27/26
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Organon & Co. (NYSE: OGN)GlobeNewsWire • 04/27/26
OGN Stock Alert: Halper Sadeh LLC is Investigating Whether Organon & Co. is Obtaining a Fair Price for its ShareholdersBusiness Wire • 04/27/26
Shareholder Alert: Ademi LLP investigates whether Organon & Co. is obtaining a Fair Price for Public ShareholdersPRNewsWire • 04/27/26
Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026Business Wire • 04/16/26
Organon's VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic DermatitisBusiness Wire • 04/15/26
Organon (OGN) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 04/13/26